Bioprekyba - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 26,125 | 36,533 | 10,729 | 16,907 | 39,859 | 45,498 | 6,821 | - |
| Profit before tax | -5,934 | -13,363 | -18,306 | -26,180 | -17,097 | -17,681 | -30,661 | -17,695 |
| Net profit | -5,934 | -13,363 | -18,306 | -26,180 | -17,097 | -17,681 | -30,661 | -17,695 |
| Equity | -4,850 | -18,213 | -36,519 | -62,699 | -79,796 | -97,477 | -128,138 | -15,195 |
| Liabilities | 28,636 | 38,639 | 65,213 | 85,146 | 113,773 | 109,211 | 135,326 | 17,421 |
| Non-current assets | 9,796 | 11,461 | 21,005 | 16,555 | 9,666 | 8,240 | 4,071 | 1,397 |
| Current assets | 13,990 | 8,965 | 7,689 | 5,892 | 24,311 | 3,494 | 3,117 | 829 |
| Total assets | 23,786 | 20,426 | 28,694 | 22,447 | 33,977 | 11,734 | 7,188 | 2,226 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 10,179 | 910 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -27.7% | +39.8% | -70.6% | +57.6% | +135.8% | +14.1% | -85.0% | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -24.9% | -65.4% | -63.8% | -116.6% | -50.3% | -150.7% | -426.6% | -794.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -22.7% | -36.6% | -170.6% | -154.8% | -42.9% | -38.9% | -449.5% | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -22.7% | -36.6% | -170.6% | -154.8% | -42.9% | -38.9% | -449.5% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,708 | 11,537 | 3,901 | 8,454 | 19,930 | 22,749 | 3,411 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioprekyba - Social security debts
The amount of overdue SODRA debt for the company Bioprekyba as of the last working day is: 1,005 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-20 | 2026-09-20 | 1004.70 |
| 2026-09-16 | 2026-09-17 | 999.33 |
| 2026-09-05 | 2026-09-15 | 465.55 |
| 2026-08-26 | 2026-09-02 | 465.55 |
| 2026-08-23 | 2026-08-23 | 533.78 |
| 2026-08-19 | 2026-08-19 | 533.78 |
| 2026-07-23 | 2026-07-26 | 5.37 |
| 2026-06-26 | 2026-07-01 | 446.52 |
| 2026-06-16 | 2026-06-25 | 499.19 |
| 2026-05-17 | 2026-05-25 | 507.06 |
| 2026-05-12 | 2026-05-14 | 7.87 |
| 2026-05-03 | 2026-05-11 | 7.85 |
| 2026-04-29 | 2026-04-29 | 7.85 |
| 2026-04-27 | 2026-04-28 | 472.42 |
| 2026-04-26 | 2026-04-26 | 464.57 |
| 2026-04-24 | 2026-04-25 | 472.42 |
| 2026-04-20 | 2026-04-23 | 464.57 |
| 2026-03-30 | 2026-04-06 | 52.60 |
| 2026-03-29 | 2026-03-29 | 1046.56 |
| 2026-03-17 | 2026-03-27 | 1046.56 |
| 2026-03-15 | 2026-03-16 | 512.78 |
| 2026-03-04 | 2026-03-11 | 512.78 |
| 2026-02-18 | 2026-03-03 | 534.17 |
| 2026-02-06 | 2026-02-17 | 0.39 |
| 2026-01-22 | 2026-02-05 | 78.49 |
| 2026-01-16 | 2026-01-21 | 78.10 |
| 2025-11-18 | 2025-11-26 | 149.55 |
| 2025-10-23 | 2025-11-16 | 5.79 |
| 2025-10-16 | 2025-10-22 | 4.63 |
| 2025-09-16 | 2025-10-14 | 4.63 |
| 2025-09-07 | 2025-09-14 | 4.63 |
| 2025-08-31 | 2025-09-03 | 4.63 |
| 2025-07-24 | 2025-08-29 | 4.63 |
| 2025-07-16 | 2025-07-22 | 476.64 |
| 2025-06-17 | 2025-06-26 | 273.69 |
| 2025-05-27 | 2025-06-01 | 479.23 |
| 2025-05-16 | 2025-05-26 | 480.50 |
| 2025-04-30 | 2025-04-30 | 365.27 |
| 2025-04-25 | 2025-04-29 | 365.57 |
| 2025-04-24 | 2025-04-24 | 365.56 |
| 2025-04-16 | 2025-04-23 | 365.27 |
| 2025-03-18 | 2025-03-23 | 160.30 |
| 2025-01-02 | 2025-01-02 | 178.13 |
| 2024-12-30 | 2024-12-31 | 178.13 |
| 2024-12-22 | 2024-12-29 | 533.86 |
| 2024-12-17 | 2024-12-20 | 533.86 |
| 2024-12-04 | 2024-12-16 | 355.73 |
| 2024-11-18 | 2024-12-03 | 369.00 |
| 2024-10-24 | 2024-11-17 | 1.10 |
| 2024-10-21 | 2024-10-23 | 0.73 |
| 2024-10-16 | 2024-10-20 | 399.37 |
| 2024-09-17 | 2024-10-15 | 0.73 |
| 2024-07-24 | 2024-09-12 | 0.73 |
| 2024-07-16 | 2024-07-23 | 0.51 |
| 2024-06-18 | 2024-07-14 | 0.51 |
| 2024-05-16 | 2024-06-16 | 0.51 |
| 2024-04-23 | 2024-05-07 | 0.51 |
| 2024-04-16 | 2024-04-18 | 182.14 |
| 2024-01-23 | 2024-03-14 | 0.22 |
| 2023-11-16 | 2023-11-19 | 389.50 |
| 2023-10-25 | 2023-11-15 | 0.37 |
| 2023-10-17 | 2023-10-24 | 0.14 |
| 2023-09-21 | 2023-10-15 | 0.14 |
| 2023-09-18 | 2023-09-20 | 131.27 |
| 2023-08-17 | 2023-09-14 | 0.14 |
| 2023-06-16 | 2023-06-19 | 97.86 |
| 2023-03-16 | 2023-03-16 | 257.48 |
| 2023-02-06 | 2023-02-16 | 0.70 |
| 2023-01-24 | 2023-02-03 | 0.70 |
| 2022-12-16 | 2022-12-19 | 72.57 |
| 2022-11-21 | 2022-12-13 | 2.76 |
| 2022-10-28 | 2022-11-18 | 2.76 |
| 2022-10-18 | 2022-10-20 | 337.39 |
| 2022-09-16 | 2022-09-22 | 294.14 |
| 2022-08-29 | 2022-09-01 | 276.96 |
| 2022-08-23 | 2022-08-28 | 337.38 |
| 2022-07-18 | 2022-07-18 | 337.38 |
| 2022-04-28 | 2022-05-12 | 0.59 |
| 2022-01-31 | 2022-02-13 | 0.93 |
| 2022-01-18 | 2022-01-23 | 281.97 |
| 2021-12-16 | 2021-12-19 | 282.40 |
| 2021-11-17 | 2021-12-15 | 0.59 |
| 2021-11-16 | 2021-11-16 | 282.40 |
| 2021-11-05 | 2021-11-15 | 0.59 |
| 2021-10-18 | 2021-10-18 | 281.81 |
Bioprekyba - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.